286 related articles for article (PubMed ID: 19682442)
1. A novel phenotype-based approach for systematically screening antiproliferation metallodrugs.
Wang YH; Cheng CC; Lee WJ; Chiou ML; Pai CW; Wen CC; Chen WL; Chen YH
Chem Biol Interact; 2009 Nov; 182(1):84-91. PubMed ID: 19682442
[TBL] [Abstract][Full Text] [Related]
2. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
3. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure, spectroscopic properties, and electrochemical oxidation of ruthenium(II) complexes Incorporating monocarboxylate bipyridine ligands.
Nickita N; Belousoff MJ; Bhatt AI; Bond AM; Deacon GB; Gasser G; Spiccia L
Inorg Chem; 2007 Oct; 46(21):8638-51. PubMed ID: 17880205
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake, cytotoxicity, and metabolic profiling of human cancer cells treated with ruthenium(II) polypyridyl complexes [Ru(bpy)2(N--N)]Cl2 with N--N=bpy, phen, dpq, dppz, and dppn.
Schatzschneider U; Niesel J; Ott I; Gust R; Alborzinia H; Wölfl S
ChemMedChem; 2008 Jul; 3(7):1104-9. PubMed ID: 18425738
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II) complexes incorporating 2-(2'-pyridyl)pyrimidine-4-carboxylic acid.
Nickita N; Gasser G; Pearson P; Belousoff MJ; Goh LY; Bond AM; Deacon GB; Spiccia L
Inorg Chem; 2009 Jan; 48(1):68-81. PubMed ID: 19053847
[TBL] [Abstract][Full Text] [Related]
7. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
Ruiz J; Vicente C; de Haro C; Bautista D
Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
[TBL] [Abstract][Full Text] [Related]
9. Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.
Palanichamy K; Sreejayan N; Ontko AC
J Inorg Biochem; 2012 Jan; 106(1):32-42. PubMed ID: 22112837
[TBL] [Abstract][Full Text] [Related]
10. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium polypyridyl complexes that induce mitochondria-mediated apoptosis in cancer cells.
Chen T; Liu Y; Zheng WJ; Liu J; Wong YS
Inorg Chem; 2010 Jul; 49(14):6366-8. PubMed ID: 20527894
[TBL] [Abstract][Full Text] [Related]
12. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
13. Ce(IV)- and light-driven water oxidation by [Ru(terpy)(pic)3]2+ analogues: catalytic and mechanistic studies.
Duan L; Xu Y; Tong L; Sun L
ChemSusChem; 2011 Feb; 4(2):238-44. PubMed ID: 21328553
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells.
Barve V; Ahmed F; Adsule S; Banerjee S; Kulkarni S; Katiyar P; Anson CE; Powell AK; Padhye S; Sarkar FH
J Med Chem; 2006 Jun; 49(13):3800-8. PubMed ID: 16789737
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Thangavel S
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):178-85. PubMed ID: 14758001
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium porphyrin compounds for photodynamic therapy of cancer.
Schmitt F; Govindaswamy P; Süss-Fink G; Ang WH; Dyson PJ; Juillerat-Jeanneret L; Therrien B
J Med Chem; 2008 Mar; 51(6):1811-6. PubMed ID: 18298056
[TBL] [Abstract][Full Text] [Related]
17. An easy electrochemical and chemical synthesis of [Ru(bpy)(CH(3)CN)(2)Cl(2)]: a synthon for heteroleptic tris(diimine) Ru(ii) complexes.
Chardon-Noblat S; Renfrew A; Lafolet F; Deronzier A; Jakonen M; Laurila E; Haukka M
Dalton Trans; 2008 Nov; (43):5891-6. PubMed ID: 19082044
[TBL] [Abstract][Full Text] [Related]
18. New approach for the preparation of efficient DNA cleaving agents: ditopic copper-platinum complexes based on 3-Clip-Phen and cisplatin.
Hoog Pd; Boldron C; Gamez P; Sliedregt-Bol K; Roland I; Pitié M; Kiss R; Meunier B; Reedijk J
J Med Chem; 2007 Jun; 50(13):3148-52. PubMed ID: 17521178
[TBL] [Abstract][Full Text] [Related]
19. A novel screening method for transition metal-based anticancer compounds using zebrafish embryo-larval assay and inductively coupled plasma-mass spectrometry analysis.
Karas BF; Côrte-Real L; Doherty CL; Valente A; Cooper KR; Buckley BT
J Appl Toxicol; 2019 Aug; 39(8):1173-1180. PubMed ID: 30963621
[TBL] [Abstract][Full Text] [Related]
20. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.
Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ
Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
